These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2430407)

  • 21. Leukotriene B4, a mediator of inflammation?
    Thorsen S
    Scand J Rheumatol; 1986; 15(3):225-36. PubMed ID: 3026033
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular inflammatory reactions in newborns and older infants.
    Prindull G
    Blut; 1968 Aug; 17(5):279-86. PubMed ID: 4874549
    [No Abstract]   [Full Text] [Related]  

  • 23. Determinants of inflammation test selection: in vitro or in vivo?
    Parnham MJ
    Agents Actions; 1986 Jan; 17(3-4):327-8. PubMed ID: 3008529
    [No Abstract]   [Full Text] [Related]  

  • 24. Dysplastic eosinophils erroneously counted as neutrophils in the automated analyser.
    Nguyen PC; Shugg C; Juneja S
    Int J Lab Hematol; 2023 Apr; 45(2):141-142. PubMed ID: 36716705
    [No Abstract]   [Full Text] [Related]  

  • 25. An hypothesis on a type of hardening.
    Stone OJ
    Contact Dermatitis; 1985 Mar; 12(3):175. PubMed ID: 3995948
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cells.
    To SS; Schrieber L
    Clin Exp Immunol; 1990 Jul; 81(1):160-5. PubMed ID: 2165879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukotrienes: mediators of inflammation and immediate hypersensitivity reactions.
    Malmsten CL
    Crit Rev Immunol; 1984; 4(4):307-34. PubMed ID: 6325090
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of the cellular response of the rat conjunctiva to topically applied leukotriene B4.
    Trocmé SD; Gilbert CM; Allansmith MR; Bloch KJ; Abelson MB
    Ophthalmic Res; 1989; 21(4):297-302. PubMed ID: 2555760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
    van de Kerkhof PC; Lammers AM; Mier PD; Happle R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; van de Kerkhof PC
    Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The perivascular cell populations in human skin after topical application of leukotriene B4.
    Winkelmann RK; Camp R; English JS; Greaves MW
    Acta Derm Venereol; 1986; 66(4):340-3. PubMed ID: 2430407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene B4: an inflammatory mediator with vascular actions in vivo.
    Bray MA
    Agents Actions Suppl; 1982; 11():51-61. PubMed ID: 6295113
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.